Clinical Trials
6 trialsNCT01636947 2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT00684463 2017-05-16
Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT00687011 2017-05-15
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT00092183 2017-05-05
An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT00415103 2009-09-18
AMENO-2
PETHEMA Foundation
Phase 4 Completed
NCT00158041 2005-09-12
Subcutaneous Amifostine Safety Study
Mt. Sinai Medical Center, Miami
Phase 4 Completed